Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
4.800
+0.580 (13.74%)
At close: Feb 6, 2026, 4:00 PM EST
4.750
-0.050 (-1.04%)
After-hours: Feb 6, 2026, 7:41 PM EST

Minerva Neurosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
2081643834100
Market Cap Growth
1275.61%-63.88%406.53%-75.19%-65.73%-64.01%
Enterprise Value
2554976403367
Last Close Price
4.802.226.151.596.4118.72
PE Ratio
-10.80---51.45
PS Ratio
-----2.42
PB Ratio
--0.60-1.51-0.424.291.90
P/TBV Ratio
-----2.64
EV/Sales Ratio
-----1.64
EV/EBITDA Ratio
-----36.24
EV/EBIT Ratio
-----36.55
Debt / Equity Ratio
-1.73-2.33-2.88-3.688.320.00
Debt / EBITDA Ratio
-----0.05
Asset Turnover
-----0.61
Quick Ratio
4.607.5312.2528.4621.558.02
Current Ratio
4.877.8512.5729.1522.078.68
Return on Equity (ROE)
-----164.60%4.83%
Return on Assets (ROA)
-25.82%-29.04%-25.81%-23.86%-27.98%1.71%
Return on Capital Employed (ROCE)
-57.60%-63.70%-43.20%-47.00%-40.60%3.40%
Earnings Yield
-6.75%9.26%-69.77%-378.15%-145.84%1.94%
FCF Yield
-6.83%-125.84%-34.38%-290.45%-71.89%-33.87%
Buyback Yield / Dilution
0.04%-16.41%-21.84%0.00%-4.41%-4.88%
Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q